These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 16273025)
1. Utilizing advanced imaging and surrogate markers across the spectrum of Alzheimer's disease. Mintun MA CNS Spectr; 2005 Nov; 10(11 Suppl 18):13-6. PubMed ID: 16273025 [TBL] [Abstract][Full Text] [Related]
2. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease. Shin J; Lee SY; Kim SH; Kim YB; Cho SJ Neuroimage; 2008 Nov; 43(2):236-44. PubMed ID: 18694837 [TBL] [Abstract][Full Text] [Related]
3. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246 [TBL] [Abstract][Full Text] [Related]
4. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm. Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Andersen P; Jonasson M; Eriksson J; Lubberink M; Almkvist O; Wall A; Antoni G; Nordberg A Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1686-99. PubMed ID: 26996778 [TBL] [Abstract][Full Text] [Related]
6. PET of brain amyloid and tau in mild cognitive impairment. Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990 [TBL] [Abstract][Full Text] [Related]
7. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A; Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175 [TBL] [Abstract][Full Text] [Related]
9. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects. Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770 [TBL] [Abstract][Full Text] [Related]
10. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Oh H; Madison C; Baker S; Rabinovici G; Jagust W Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008 [TBL] [Abstract][Full Text] [Related]
11. Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease. Zeng F; Goodman MM Curr Top Med Chem; 2013; 13(8):909-19. PubMed ID: 23590167 [TBL] [Abstract][Full Text] [Related]
16. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353 [TBL] [Abstract][Full Text] [Related]
17. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050 [TBL] [Abstract][Full Text] [Related]
18. Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary. Rabinovici GD; Karlawish J; Knopman D; Snyder HM; Sperling R; Carrillo MC Alzheimers Dement; 2016 Apr; 12(4):510-5. PubMed ID: 27103054 [TBL] [Abstract][Full Text] [Related]
19. Quantification of Tau Load in Alzheimer's Disease Clinical Trials Using Positron Emission Tomography. Timmers T; van Berckel BNM; Lammertsma AA; Ossenkoppele R Methods Mol Biol; 2018; 1750():221-229. PubMed ID: 29512076 [TBL] [Abstract][Full Text] [Related]
20. A Novel Magnetic Nanoparticle for Early Detection of Amyloid Plaques in Alzheimer's Disease. Zeng J; Wu J; Li M; Wang P Arch Med Res; 2018 May; 49(4):282-285. PubMed ID: 30266531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]